B O O K - American College of Rheumatology

Rheumatoid Arthritis: Clinical Aspects
Deborah P. Symmons, MD; Arthritis Research UK Epidemiology
Unit; Manchester, United Kingdom
Rheumatoid Arthritis Treatment: Small Molecules, Biologic and
Gene Therapy
Martin Aringer, MD; Uniklinikum TU Dresden; Dresden, Germany
Systemic Lupus Erythematosus: Clinical Aspects
Eliza Chakravarty, MD; Stanford University; Mountain View, CA
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s:
Clinical Aspects and Therapeutics
Maureen D. Mayes, MD, MPH; University of Texas-Houston;
Houston, TX
Exhibits and Replay Café
9:00 am - 7:00 pm
Halls A1 & A2
Exhibits
Halls A1 & A2 (Booth #123)
Replay Café
Exhibit Hall Morning SnACk Break
9:00 - 10:00 AM
Halls A1 & A2
tuesday
10:15 - 11:00 am
Behavioral Science
Susan J. Bartlett, PhD, McGill University, Montreal, Canada
Pain
Carol L. Baird, DNS, ARPN, BC, Indiana University, Indianapolis,
IN
Muscle Biology, Myositis and Myophathies
Frederick W. Miller, MD, PhD; National Institute of
Environmental Health Sciences, NIH, Kennsington, MD
Osteoporosis and Metabolic Bone Disease: Clinical Aspects and
Pathogenesis
Nancy E. Lane, MD; University of California-Davis, Hillsborough,
CA
Rheumatoid Arthritis: Clinical Aspects
Larry W. Moreland, MD; University of Pittsburgh Medical Center;
Pittsburgh, PA
Rheumatoid Arthritis Treatment: Small Molecules, Biologic and
Gene Therapy
Eric M. Ruderman, MD; Northwestern University School;
Chicago, IL
Systemic Lupus Erythematosus: Human Etiology and
Pathogenesis
Mary K. Crow, MD; Hospital for Special Surgery; New York, NY
4:30 - 5:30 PM
Fibromyalgia and Soft Tissue Disorder
Daniel J. Clauw, MD; University of Michigan Chronic Pain &
Fatigue Research; Ann Arbor, MI
Osteoarthritis - Clinical Aspects
Timothy E. McAlindon, MD, MPH; Tufts Medical Center, Boston,
MA
Rheumatoid Arthritis: Clinical Aspects
Jonathan Kay, MD; UMass Memorial Medical Center; Worcester,
MA
Vasculitis
Alexandra Villa-Forte, MD, MPH; Cleveland Clinic Foundation;
Cleveland, OH
Poster Hall Morning SnACk Break
9:00 - 10:30 am
Halls B1 & B2
ARHP Concurrent Abstract Session
9:15 - 10:15 am
B311
Physical and Psychosocial Challenges in Scleroderma
Moderator: Jane S. Brandenstein, BS, PT; Freedom, PA
9:15 am
1346. Frequency and Impact of Symptoms Experienced by
Patients with Systemic Sclerosis: Results from a Canadian
National Survey.
Marielle Bassel 1 , Marie Hudson 3 , Suzanne S. Taillefer 4 , Orit
Schieir 1 , Murray Baron 1 and Brett D. Thombs 2 , 1 Jewish General
Hospital, Montreal, QC, Canada, 2 McGill University, Montreal,
QC, Canada, 3 McGill University and Jewish General Hospital,
4
SMBD Jewish General Hospital, Montreal, QC, Canada
9:30 am
1347. Sociodemographic and Disease Correlates of Body Image
in Systemic Sclerosis (SSc).
Lisa R. Jewett 2 , Marie Hudson 3 , Murray Baron 1 , Brett D. Thombs 2
and Canadian Scleroderma Research Group (CSRG), 1 Jewish
General Hospital, Montreal, QC, Canada, 2 McGill University,
Montreal, QC, Canada, 3 McGill University and Jewish General
Hospital
9:45 am
1348. Development and Validation of the Brief-Satisfaction
with Appearance Scale (Brief-SWAP) for Measuring Body Image
in Systemic Sclerosis (SSc).
Lisa R. Jewett 4 , Marie Hudson 5 , Jennifer A. Haythornthwaite 3 ,
Leslie Heinberg 1 , Fredrick M. Wigley 3 , Murray Baron 2 , Brett D.
Thombs 4 and Canadian Scleroderma Research Group (CSRG),
1
Cleveland Clinic Lerner College of Medicine of Case Western
Reserve University, 2 Jewish General Hospital, Montreal, QC,
Canada, 3 Johns Hopkins University School of Medicine, 4 McGill
University, Montreal, QC, Canada, 5 McGill University and Jewish
General Hospital
60
2010 Program Book